MORPHOLOGY OFFERS CLUES TO ISCHEMIA PATHOGENESIS
In the 1970s, Brown and Brierley 2 described the prodromal morphologic features of ischemic cell change as that of microvacuolization in selectively vulnerable neurons (Figure 1 ). In 1984, Brian Meldrum and I, 3 working at the Institute of Psychiatry in London, England, looked again at these vacuoles. We used ultrastructural studies of ischemic brain treated with the then new oxalate-pyroantimonate technique, with which calcium could be visualized as electron-dense deposits. Almost all of the microvacuoles were shown to be the result of mitochondrial dilation, and the dilated mitochondrial were further characterized by marked calcium loading (Figure 2) . Thus, mitochondrial failure and intracellular calcium toxicity were demonstrated morphologically as central features of ischemic brain injury. 3 This interesting result seemed similar to microvacuolization and mitochondrial calcium loading shown to occur with status epilepticus by Griffiths and Meldrum. Inasmuch as this receptor and epileptogenesis can be blocked by glutamate antagonists, Meldrum 5 hypothesized that enhanced calcium entry during epileptic burst firing and ischemia may have a joint mechanism driven by NMDA function. Previous comparisons of NMDA activation in cortex or spinal cord had shown preferential blockade by APH (2-amino-7-phosphonoheptanoic acid). Thus, APH was studied by a simple experiment of injectingthedrugintoonehippocampusand the diluent into the contralateral hippocampus in the brain of a rat just before induction of global ischemia. Robust protection occurred in each of the pyramidal cell subsectors of the APH-infused hippocampus. 6 Thus,pharmacologicblockadeoftheNMDA receptor protected against ischemic injury in vivo. These results were highlighted by nearly simultaneous experiments in Copenhagen, Denmark, using another technique, microdialysis, which was new at the time. Benveniste and Diemer 7 showed an 8-fold increase in extracellular glutamate concentration during global ischemia in the rat brain. Thus, by 1984, the excitotoxic theory of ischemicbraininjurywasdemonstratedinvivo.
FAILURE OF CLINICAL TRIALS
Subsequently NMDA receptor and non-NMDA receptor structure and function were studied in detail. Using the multiple mechanisms discovered to modulate glutamate receptor function, a host of clinical trials followed. To date, none have shown efficacy in stroke. Many ideas were advanced to explain these failures. Among these was an observation made in a world distant from that of ischemia research-the Department of Biophysics at the University of Pennsylvania, Philadelphia. Excitatory amino acid receptor gated-channel currents in chick retinal ganglion cells were studied at varying pH levels. The NMDA receptor alone was found to be pH sensitive, with channel currents nearly abolished at pH 6.6. 
ACID-SENSING ION CHANNELS IN THE BRAIN
The role of acidotoxicity in brain ischemia lay hidden in 2 brief articles from the Ukraine published in 1980 9 and 1981 10 in which a membrane receptor for hydrogen ions was discovered in nerve cell membranes "by a chain of accidental events . . .
[of] . . . sheer fantasy." 11(p477) Acid-sensing ion channels (ASICs) belong to the degenerin-epithelial sodium channel superfamily of amiloride-sensitive sodium-selective cation channels. The neurotransmitter for these receptorgated channels is the proton (hydrogen ion). There are 4 ASIC genes encoding 6 polypeptides: ASIC1, a and b; ASIC2, a and b; ASIC3; and ASIC4. Each exists as a quadrameric structure and has distinct pH sensitivities, kinetics, and conduction properties, which are most germane to ASIC1a and ASIC2a,inasmuchastheyarethemajorsubunitsinthebrain. The pH 0.5 (half-maximum activation pH) is 6.2 for ASIC1a in its homomeric conformation and 4.4 for homomeric ASIC2a. Heteromeric channels have properties distinct from homomeric channels. The ASICs are expressed throughout the brain, where they are thought to have a role in modulation of normal synaptic neurotransmission (presynaptic vesicle pH, 5.5). Because the pH in ischemic brain is 6.0 to 6.5 with normoglycemia, the ASIC1a channel is likely activated in stroke. Further germane to ischemia, this sodium channel is also permeable to calcium.
ACIDOTOXICITY
A pH dependency can be demonstrated in mouse cortical neurons using whole-cell patch clamp. Current activated by a decrease in pH from 7.4 through 5.0 can be demonstrated, and when the dose-response curves are fit to the Hill equation, the average pH 0.5 is 6.18, which suggests a predominance of homomeric ASIC1a channels. The current-voltage relationship shows a reversal close to the sodium equilibrium potential, as would be expected of a sodium channel. As ASICs belonging to the degenerinepithelial sodium channel family, they are amiloride sensitive. A specific antagonist of the ASIC1a channel is the peptide PcTX1 found in the venom of a South American tarantula (Psalmotoxin cambridgei). PcTX1 markedly attenuates acid-induced currents at nanogram concentrations. These acid currents injure cells, as shown by lactic dehydrogenase measurements from mouse cortical cultures treated at pH 6.0 for 1 hour and observed for 24 hours. The injury occurs in the setting of blockade of NMDA, AMPA (␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), and voltage-dependent calcium channels. Thus, acidotoxicity is glutamate independent. The injury is calcium and ASIC1a dependent because acid injury can be blocked by low calcium concentrations in the medium, injury can be induced by transfection of Chinese hamster ovary cells with ASIC1a complementary DNA, and acidinduced injury at pH 6.0 does not occur in cortical cultures from ASIC1a knockout mice. Accordingly, acidinduced calcium toxicity is also glutamate independent. Thus, acidosis produces neuronal injury through the ASIC1a channel, which is calcium dependent but glutamate independent. But the link between ASICs and ischemic injury is even stronger because acid currents measured in the setting of modeled ischemia with oxygen and glucose deprivation have substantially increased induced current amplitude and substantially decreased desensitization (ie, the channels remain open longer) (Figure 3) . Thus, the ASIC channels respond to both of the major neurochemical elements of ischemia: acidosis and substrate depletion.
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BLOCKADE OF ASICS AS A NEW THERAPY FOR STROKE
In vitro studies predict that ASIC1a gated channels may be involved in stroke. To investigate this possibility, (Figure 4) . Thus, acidotoxicity trumps excitotoxity in ischemic stroke.
CODA
What about the ASIC2a channel protein? With a pH 0.5 of 4.4, can it have a role in stroke? To answer this question, we used global ischemia in rats and showed an increase in ASIC2a protein during the 72 hours of reperfusion. We then stained hippocampal sections for ASIC2a-like immunoreactivity and double stained the sections with a marker for single-or double-stranded DNA breaks. No ASIC2a-positive cell also labeled with the DNA damage marker. 13 Thus, up-regulation of the ASIC2a subunit may confer protection after ischemia, probably by binding with ASIC1a protein subunits to form heteromeric ASIC1a-ASIC2a channels. Whole-cell patch of such heteromeric channels shows marked attenuation of acidinduced currents in glucose-free media.
CONCLUSIONS
Thus, ASICs, which are abundant in brain, flux calcium and are activated by hydrogen ion, and oxygen and glucose deprivation. They cause injury via the ASIC1a subunit and may modulate injury via the ASIC2a subunit.
Hence, ASICs are new, glutamate-independent targets for neuroprotection in stroke. 
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